Experiences with
Ibrutinib2,003 public posts
Want to take advantage of all our features? Just log in!
or
Cancer drug found to contain life-threatening bacteria
Incidentally, there are allegedly the same issues in China where the FDA theoretically oversea some drug production but they are obfuscated from inspecting production and QA records
It’s worth noting that Ibrutinib will be coming off patent soon and may be manufactured in India.
Zanubrutinib PFS, ORR Is Superior to Ibrutinib for Relapsed/Refractory CLL/SLL
The median treatment duration was 28.4 months with zanubrutinib vs 24.3 months for ibrutinib. AEs led to a dose reduction for 12.3% of those in the zanubrutinib arm and for 17.0% of those in the ibrutinib group.
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
Brown is very clear about the advantages of Zanubrutinib over Ibrutinib - especially for 17p and patients with heart risks.
https://www.patientpower.info/chronic-lymphocytic-leukemia/2022-ash-conference-report-cll-btk-inhibitors-update?